Duke University’s Margolis Center for Health Policy, in cooperation with the FDA, held a public workshop Safe Use of Benzodiazepines: Clinical, Regulatory, and Public Health Perspectives on July 12 and 13. Our director, Dr. Christy Huff,…
Hi, I’m a Trainee Counselling Psychologist at the University of East London researching people’s experiences of ongoing healing from benzodiazepine physical dependence, withdrawal and/or protracted harm. The aim is to explore the ongoing experience of…
Sonja Styblo from our general advisory board talks about the importance of language and why the term cold turkey can be problematic. Why is the term “cold turkey” confusing to prescribers and outsiders? As noted…
Please join us in welcoming Dr. Josef Witt-Doerring back our medical advisory board. Dr. Witt-Doerring is a board-certified psychiatrist who runs a private practice that specializes in helping patients safely discontinue psychiatric medications. Dr. Witt-Doerring interest…
Please join us in welcoming Dr. Harold Gottlieb to our medical advisory board. Dr. Gottlieb has served as a Chief Medical Officer for many years. He was the Gulf Coast Regional Chief Medical Officer for CHRISTUS…
We have released an updated version of our benzodiazepine informed consent. Authored by Dr. Christy Huff at Benzodiazepine Information Coalition and Dr. Steven Wright at the Alliance for Benzodiazepine Best Practices, the consent form is…
Dr. Christy Huff presented Safe Prescribing Protocols of Benzodiazepines: Lessons Learned from the Opioid Crisis alongside Dr. Alexis Ritvo on July 18, 2021. [pdf id=17349]
Hosted by neuropsychiatrist Sotiris ”Pospo” Posporelis, this episode focused on benzodiazepines and featured Professor Edward K. Silberman. Knowing Dr. Silberman’s history, I was concerned that the podcast might result in spreading misinformation to prescribers and stigmatizing harmed patients. While the interview did get some important things right, my suspicions were ultimately confirmed.
